Intriguingly, irisin withdrawal in CKD mice for 2 weeks resulted in low bone mineral density (BMD) in CKD mice similar to vehicle-treated CKD mice (Figure 3C), underscoring the necessity for continuous irisin therapy to prevent renal osteodystrophy. Here, FNDC5 is linked to chronic kidney disease.